Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Glioma | Research

Expression profiles and function prediction of tRNA-derived fragments in glioma

Authors: Deng Wei, Ben Niu, Bei Zhai, Xiao-bai Liu, Yi-long Yao, Chan-chan Liang, Ping Wang

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Glioblastoma (GBM) is the most aggressive malignant primary brain tumor. The transfer RNA-derived fragments (tRFs) are a new group of small noncoding RNAs, which are dysregulated in many cancers. Until now, the expression and function of tRFs in glioma remain unknown.

Methods

The expression profiles of tRF subtypes were analyzed using the Cancer Genome Atlas (TCGA)-low-grade gliomas (LGG)/GBM dataset. The target genes of tRFs were subjected to Gene Ontology, Kyoto Encyclopedia and Gene set enrichment analysis of Genes and Genomes pathway enrichment analysis. The protein-protein interaction enrichment analysis was performed by STRING. QRT-PCR was performed to detect the expressions of tRFs in human glioma cell lines U87, U373, U251, and human astrocyte cell line SVG p12. Western blot assay was used to detect to the expression of S100A11. The interaction between tRF-19-R118LOJX and S100A11 mRNA 3’UTR was detected by dual-luciferase reporter assay. The effects of tRF-19-R118LOJX, tRF-19-6SM83OJX and S100A11 on the glioma cell proliferation, migration and in vitro vasculogenic mimicry formation ability were examined by CCK-8 proliferation assay, EdU assay, HoloMonitor cell migration assay and tube formation assay, respectively.

Results

tRF-19-R118LOJX and tRF-19-6SM83OJX are the most differentially expressed tRFs between LGG and GBM groups. The functional enrichment analysis showed that the target genes of tRF-19-R118LOJX and tRF-19-6SM83OJX are enriched in regulating blood vessel development. The upregulated target genes are linked to adverse survival outcomes in glioma patients. tRF-19-R118LOJX and tRF-19-6SM83OJX were identified to suppress glioma cell proliferation, migration, and in vitro vasculogenic mimicry formation. The mechanism of tRF-19-R118LOJX might be related to its function as an RNA silencer by targeting the S100A11 mRNA 3’UTR.

Conclusion

tRFs would become novel diagnostic biomarkers and therapeutic targets of glioma, and the mechanism might be related to its post-transcriptionally regulation of gene expression by targeting mRNA 3’UTR.
Appendix
Available only for authorised users
Literature
1.
Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA Cancer J Clin. 2020;70(4):299–312.PubMedCrossRef
2.
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2012–2016. Neuro Oncol. 2019;21(Suppl 5):v1–v100.PubMedCentralCrossRef
3.
Shahzad U, Krumholtz S, Rutka JT, Das S. Noncoding RNAs in Glioblastoma: emerging Biological concepts and potential therapeutic implications. Cancers (Basel). 2021;13(7):1555.PubMedCrossRef
4.
Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. LncRNA PVT1 facilitates tumorigenesis and progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway. Neurotherapeutics. 2018;15(4):1139–57.PubMedPubMedCentralCrossRef
5.
Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 2022;21(1):16.PubMedPubMedCentralCrossRef
6.
Xia XR, Li WC, Yu ZT, Li J, Peng CY, Jin L, Yuan GL. Effects of small nucleolar RNA SNORD44 on the proliferation, apoptosis and invasion of glioma cells. Histochem Cell Biol. 2020;153(4):257–69.PubMedCrossRef
7.
Sadova AA, Kupriyanova NS, Pavlova GV. Mapping and quantification of non-coding RNA originating from the rDNA in human glioma cells. Cancers (Basel). 2020;12(8):2090.PubMedCrossRef
8.
9.
Kim HK, Fuchs G, Wang S, Wei W, Zhang Y, Park H, et al. A transfer-RNA-derived small RNA regulates ribosome biogenesis. Nature. 2017;552(7683):57–62.PubMedPubMedCentralCrossRef
10.
Kuscu C, Kumar P, Kiran M, Su Z, Malik A, Dutta A. tRNA fragments (tRFs) guide ago to regulate gene expression post-transcriptionally in a dicer-independent manner. RNA. 2018;24(8):1093–105.PubMedPubMedCentralCrossRef
11.
Kumar P, Anaya J, Mudunuri SB, Dutta A. Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets. BMC Biol. 2014;12:78.PubMedPubMedCentralCrossRef
12.
Saikia M, Jobava R, Parisien M, Putnam A, Krokowski D, Gao XH, et al. Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress. Mol Cell Biol. 2014;34(13):2450–63.PubMedPubMedCentralCrossRef
13.
Maute RL, Schneider C, Sumazin P, Holmes A, Califano A, Basso K, Dalla-Favera R. tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell Lymphoma. Proc Natl Acad Sci U S A. 2013;110(4):1404–9.PubMedPubMedCentralCrossRef
14.
Cao KY, Yan TM, Zhang JZ, Chan TF, Li J, Li C, et al. A tRNA-derived fragment from Chinese yew suppresses Ovarian cancer growth via targeting TRPA1. Mol Ther Nucleic Acids. 2022;27:718–32.PubMedPubMedCentralCrossRef
15.
Goodarzi H, Liu X, Nguyen HC, Zhang S, Fish L, Tavazoie SF. Endogenous tRNA-Derived fragments suppress Breast Cancer progression via YBX1 displacement. Cell. 2015;161(4):790–802.PubMedPubMedCentralCrossRef
16.
Liu X, Mei W, Padmanaban V, Alwaseem H, Molina H, Passarelli MC, Tavora B, Tavazoie SF. A pro-metastatic tRNA fragment drives Nucleolin oligomerization and stabilization of its bound metabolic mRNAs. Mol Cell. 2022;82(14):2604–2617e2608.PubMedPubMedCentralCrossRef
17.
Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A. 1985;82(4):1257–61.PubMedPubMedCentralCrossRef
18.
Schweighardt B, Atwood WJ. HIV type 1 Infection of human astrocytes is restricted by inefficient viral entry. AIDS Res Hum Retroviruses. 2001;17(12):1133–42.PubMedCrossRef
19.
20.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.PubMedPubMedCentralCrossRef
21.
Kar RK, Hanner AS, Starost MF, Springer D, Mastracci TL, Mirmira RG, Park MH. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice. J Biol Chem. 2021;297(5):101333.PubMedPubMedCentralCrossRef
22.
Kim HK, Yeom JH, Kay MA. Transfer RNA-Derived small RNAs: another layer of Gene Regulation and Novel targets for Disease therapeutics. Mol Ther. 2020;28(11):2340–57.PubMedPubMedCentralCrossRef
23.
Yu X, Xie Y, Zhang S, Song X, Xiao B, Yan Z. tRNA-derived fragments: mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus Infections. Theranostics. 2021;11(1):461–9.PubMedPubMedCentralCrossRef
24.
Cole C, Sobala A, Lu C, Thatcher SR, Bowman A, Brown JW, Green PJ, Barton GJ, Hutvagner G. Filtering of deep sequencing data reveals the existence of abundant dicer-dependent small RNAs derived from tRNAs. RNA. 2009;15(12):2147–60.PubMedPubMedCentralCrossRef
25.
Haussecker D, Huang Y, Lau A, Parameswaran P, Fire AZ, Kay MA. Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA. 2010;16(4):673–95.PubMedPubMedCentralCrossRef
26.
Megel C, Hummel G, Lalande S, Ubrig E, Cognat V, Morelle G, Salinas-Giege T, Duchene AM, Marechal-Drouard L. Plant RNases T2, but not Dicer-like proteins, are major players of tRNA-derived fragments biogenesis. Nucleic Acids Res. 2019;47(2):941–52.PubMedCrossRef
27.
Di Fazio A, Schlackow M, Pong SK, Alagia A, Gullerova M. Dicer dependent tRNA derived small RNAs promote nascent RNA silencing. Nucleic Acids Res. 2022;50(3):1734–52.PubMedPubMedCentralCrossRef
28.
Panoutsopoulou K, Dreyer T, Dorn J, Obermayr E, Mahner S, Gorp TV, et al. tRNAGlyGCC-Derived internal fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression. Cancers (Basel). 2021;14(1):24.PubMedCrossRef
29.
Lu Z, Su K, Wang X, Zhang M, Ma S, Li H, Qiu Y. Expression profiles of tRNA-Derived small RNAs and their potential roles in primary nasopharyngeal carcinoma. Front Mol Biosci. 2021;8:780621.PubMedPubMedCentralCrossRef
30.
Kazimierczyk M, Wojnicka M, Biala E, Zydowicz-Machtel P, Imiolczyk B, Ostrowski T, Kurzynska-Kokorniak A, Wrzesinski J. Characteristics of transfer RNA-Derived fragments expressed during human renal cell development: the role of Dicer in tRF Biogenesis. Int J Mol Sci. 2022;23(7):3644.PubMedPubMedCentralCrossRef
31.
Fang Y, Liu Y, Yan Y, Shen Y, Li Z, Li X, et al. Differential expression profiles and function predictions for tRFs & tiRNAs in skin Injury Induced by Ultraviolet Irradiation. Front Cell Dev Biol. 2021;9:707572.PubMedPubMedCentralCrossRef
32.
Zhu XL, Li T, Cao Y, Yao QP, Liu X, Li Y, et al. tRNA-derived fragments tRF(GlnCTG) induced by arterial injury promote vascular smooth muscle cell proliferation. Mol Ther Nucleic Acids. 2021;23:603–13.PubMedCrossRef
33.
Soares AR, Fernandes N, Reverendo M, Araujo HR, Oliveira JL, Moura GM, Santos MA. Conserved and highly expressed tRNA derived fragments in zebrafish. BMC Mol Biol. 2015;16:22.PubMedPubMedCentralCrossRef
34.
Drino A, Oberbauer V, Troger C, Janisiw E, Anrather D, Hartl M, Kaiser S, Kellner S, Schaefer MR. Production and purification of endogenously modified tRNA-derived small RNAs. RNA Biol. 2020;17(8):1104–15.PubMedPubMedCentralCrossRef
35.
Yang WQ, Xiong QP, Ge JY, Li H, Zhu WY, Nie Y, et al. THUMPD3-TRMT112 is a m2G methyltransferase working on a broad range of tRNA substrates. Nucleic Acids Res. 2021;49(20):11900–19.PubMedPubMedCentralCrossRef
36.
Clark WC, Evans ME, Dominissini D, Zheng G, Pan T. tRNA base methylation identification and quantification via high-throughput sequencing. RNA. 2016;22(11):1771–84.PubMedPubMedCentralCrossRef
37.
Vilardo E, Amman F, Toth U, Kotter A, Helm M, Rossmanith W. Functional characterization of the human tRNA methyltransferases TRMT10A and TRMT10B. Nucleic Acids Res. 2020;48(11):6157–69.PubMedPubMedCentralCrossRef
38.
Dai Z, Liu H, Liao J, Huang C, Ren X, Zhu W, et al. N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Mol Cell. 2021;81(16):3339–3355e3338.PubMedCrossRef
39.
Orellana EA, Liu Q, Yankova E, Pirouz M, De Braekeleer E, Zhang W, et al. METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation. Mol Cell. 2021;81(16):3323–3338e3314.PubMedPubMedCentralCrossRef
40.
Wang B, Li D, Ilnytskyy Y, Kovalchuk I, Kovalchuk O. A miR-34a-guided, tRNA(i)(Met)-derived, piR_019752-like fragment (tRiMetF31) suppresses migration and angiogenesis of Breast cancer cells via targeting PFKFB3. Cell Death Discov. 2022;8(1):355.PubMedPubMedCentralCrossRef
41.
Nemec CM, Singh AK, Ali A, Tseng SC, Syal K, Ringelberg KJ, et al. Noncanonical CTD kinases regulate RNA polymerase II in a gene-class-specific manner. Nat Chem Biol. 2019;15(2):123–31.PubMedCrossRef
42.
Xiao Y, Zhao H, Tian L, Nolley R, Diep AN, Ernst A, et al. S100A10 is a critical mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma. Cancer Res. 2019;79(22):5758–68.PubMedPubMedCentralCrossRef
43.
Ishikawa M, Osaki M, Yamagishi M, Onuma K, Ito H, Okada F, Endo H. Correlation of two distinct metastasis-associated proteins, MTA1 and S100A4, in angiogenesis for promoting Tumor growth. Oncogene. 2019;38(24):4715–28.PubMedCrossRef
44.
Lee HY, Chen CK, Ho CM, Lee SS, Chang CY, Chen KJ, Jou YS. EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma. Oncotarget. 2018;9(17):13193–205.PubMedPubMedCentralCrossRef
45.
Tu Y, Xie P, Du X, Fan L, Bao Z, Sun G, et al. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-kappaB positive feedback loop. J Cell Mol Med. 2019;23(10):6907–18.PubMedPubMedCentralCrossRef
Metadata
Title
Expression profiles and function prediction of tRNA-derived fragments in glioma
Authors
Deng Wei
Ben Niu
Bei Zhai
Xiao-bai Liu
Yi-long Yao
Chan-chan Liang
Ping Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11532-8

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue

Research

Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center

Study Protocol

HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial

Research

Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients

Research

Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer

Research

Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer

Study Protocol

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – the randomized phase III PRIMA-CNS trial
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits